Neville Rodie & Shaw’s Gilead Sciences GILD Stock Holding History

Neville Rodie & Shaw’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.88M	Hold	14,844	–	–	0.12%	99
2026 Q1	$2.07M	Sell	14,844 -737	-5%	-$103K	0.15%	90
2025 Q4	$1.91M	Hold	15,581	–	–	0.14%	93
2025 Q3	$1.73M	Hold	15,581	–	–	0.13%	99
2025 Q2	$1.73M	Hold	15,581	–	–	0.13%	100
2025 Q1	$1.75M	Buy	15,581 +855	+6%	+$88.2K	0.14%	97
2024 Q4	$1.36M	Sell	14,726 -125	-0.8%	-$11.3K	0.1%	117
2024 Q3	$1.25M	Sell	14,851 -845	-5%	-$64.5K	0.09%	121
2024 Q2	$1.08M	Sell	15,696 -300	-2%	-$20K	0.08%	130
2024 Q1	$1.17M	Hold	15,996	–	–	0.09%	123
2023 Q4	$1.3M	Sell	15,996 -125	-0.8%	-$9.73K	0.11%	114
2023 Q3	$1.21M	Hold	16,121	–	–	0.11%	108
2023 Q2	$1.24M	Sell	16,121 -2,200	-12%	-$175K	0.11%	109
2023 Q1	$1.52M	Hold	18,321	–	–	0.14%	94
2022 Q4	$1.57M	Hold	18,321	–	–	0.15%	96
2022 Q3	$1.13M	Sell	18,321 -300	-2%	-$18.9K	0.11%	114
2022 Q2	$1.15M	Buy	18,621 +767	+4%	+$47.5K	0.1%	117
2022 Q1	$1.06M	Sell	17,854 -400	-2%	-$25.6K	0.08%	132
2021 Q4	$1.32M	Sell	18,254 -100	-0.5%	-$6.89K	0.09%	120
2021 Q3	$1.28M	Hold	18,354	–	–	0.1%	116
2021 Q2	$1.26M	Sell	18,354 -860	-4%	-$57.4K	0.1%	117
2021 Q1	$1.24M	Sell	19,214 -2,912	-13%	-$188K	0.1%	118
2020 Q4	$1.29M	Sell	22,126 -1,552	-7%	-$93.6K	0.11%	106
2020 Q3	$1.5M	Sell	23,678 -1,725	-7%	-$120K	0.14%	96
2020 Q2	$1.96M	Sell	25,403 -2,475	-9%	-$190K	0.2%	84
2020 Q1	$2.08M	Sell	27,878 -2,297	-8%	-$159K	0.25%	80
2019 Q4	$1.96M	Sell	30,175 -515	-2%	-$33.5K	0.19%	97
2019 Q3	$1.95M	Sell	30,690 -1,125	-4%	-$73.5K	0.21%	96
2019 Q2	$2.15M	Sell	31,815 -5,306	-14%	-$349K	0.23%	93
2019 Q1	$2.41M	Sell	37,121 -2,934	-7%	-$195K	0.26%	88
2018 Q4	$2.5M	Sell	40,055 -719	-2%	-$50.3K	0.3%	82
2018 Q3	$3.15M	Sell	40,774 -279	-0.7%	-$21.1K	0.31%	83
2018 Q2	$2.91M	Buy	41,053 +374	+0.9%	+$26.4K	0.31%	86
2018 Q1	$3.07M	Sell	40,679 -233	-0.6%	-$18.5K	0.34%	78
2017 Q4	$2.93M	Sell	40,912 -69	-0.2%	-$5.24K	0.31%	83
2017 Q3	$3.32M	Sell	40,981 -1,149	-3%	-$87.9K	0.37%	77
2017 Q2	$2.98M	Sell	42,130 -13,016	-24%	-$866K	0.34%	79
2017 Q1	$3.75M	Sell	55,146 -20,360	-27%	-$1.43M	0.43%	74
2016 Q4	$5.41M	Sell	75,506 -16,839	-18%	-$1.25M	0.64%	53
2016 Q3	$7.31M	Sell	92,345 -11,098	-11%	-$902K	0.86%	35
2016 Q2	$8.63M	Sell	103,443 -9,174	-8%	-$814K	1.03%	28
2016 Q1	$10.3M	Sell	112,617 -33,844	-23%	-$3.05M	1.26%	20
2015 Q4	$14.8M	Sell	146,461 -4,264	-3%	-$444K	1.78%	8
2015 Q3	$14.8M	Buy	150,725 +7,481	+5%	+$831K	1.81%	9
2015 Q2	$16.8M	Sell	143,244 -3,910	-3%	-$427K	1.84%	7
2015 Q1	$14.4M	Buy	147,154 +17,335	+13%	+$1.76M	1.5%	15
2014 Q4	$12.2M	Sell	129,819 -755	-0.6%	-$78.1K	1.24%	19
2014 Q3	$13.9M	Sell	130,574 -1,265	-1%	-$124K	1.37%	18
2014 Q2	$10.9M	Sell	131,839 -601	-0.5%	-$46.8K	1.1%	25
2014 Q1	$9.38M	Sell	132,440 -2,365	-2%	-$185K	1.02%	29
2013 Q4	$10.1M	Buy	134,805 +13,050	+11%	+$909K	1.1%	28
2013 Q3	$7.66M	Sell	121,755 -1,275	-1%	-$76.2K	0.89%	31
2013 Q2	$6.31M	Buy	+123,030	New	+$6.41M	0.76%	37

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Neville Rodie & Shaw's GILD Position: Q2 2026 in Review

Neville Rodie & Shaw held its Gilead Sciences (GILD) position steady in Q2 2026 at 14,844 shares worth $1.88M. The position accounts for 0.12% of the portfolio, ranked #99.

Neville Rodie & Shaw first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.8M in Q2 2015. 837 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Neville Rodie & Shaw held 14,844 shares of Gilead Sciences worth $1.88M as of Q2 2026.
Neville Rodie & Shaw left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.12% of Neville Rodie & Shaw's portfolio in Q2 2026, its #99 holding.
Neville Rodie & Shaw first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
Neville Rodie & Shaw's Gilead Sciences position peaked at $16.8M in Q2 2015.
837 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Neville Rodie & Shaw's 13F filing for Q2 2026, filed 6 Jul 2026.